If all goes well, Artemis 2 could launch as soon as March 6. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Breaking space news, the latest ...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether ResMed's current share price lines up with its underlying worth ...
SYDNEY, Feb 3 (Reuters) - Sleep-breathing device maker ResMed (RMD.N), opens new tab plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style ...
ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business model. I rate RMD a strong sell due to the imminent threat from Apnimed's ...
(RTTNews) - Resmed Inc (RMD.AX) released earnings for its second quarter that Increases, from last year The company's earnings totaled $392.59 million, or $2.68 per share. This compares with $344.62 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal second-quarter net income of $392.6 million. On a per-share basis, the San Diego-based company said it had net income of ...
ResMed beat estimated earnings by 4.0%, reporting an EPS of $2.81 versus an estimate of $2.71. Revenue was up $140.81 million from the same period last year. The company beat on EPS by $0.05 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results